Biogen (BIIB) Operating Income (2009 - 2026)
Biogen (BIIB) reported Operating Income of -$9 million for Q3 2026, compared with $557.3 million a year earlier.
Powered by 
Analysis
Biogen (BIIB) Operating Income (2009 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Biogen's Operating Income came in at $445.1 million, down 76.6% year-over-year; for FY2025, it came in at $1.56 billion, down 18.3% from FY2024.
- Operating Income has a five-year compound annual growth rate of -19.3% (FY2020 to FY2025).
- By year, Operating Income came in at $1.91 billion in FY2024 (+47.0%), $1.3 billion in FY2023 (-63.9%), $3.59 billion in FY2022 (+26.4%) and $2.84 billion in FY2021 (-37.6%).
- Five-year quarterly Operating Income spans a low of -$141.2 million in Q3 2023 and a high of $1.37 billion in Q3 2022.
- Year over year, Operating Income gained in three of the last six quarters, with an average decline of 10.6%.
- The high point for year-over-year Operating Income in five years was Q2 2022 (growth of 161.4%); the low point was Q2 2026 (a decline of 82.2%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $132.4 million (Q2 2026), $377.7 million (Q1 2026) and -$56 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 8.41 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 6.27 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 5.56 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 4.39 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 3.71 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 3.46 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 5.47 Bn |
| 10 | Biogen | 37.46 Bn | 26.77 Bn | 2.06 Bn | -9.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -9.00 Mn |
| Jun 30, 2026 | 132.40 Mn |
| Mar 31, 2026 | 377.70 Mn |
| Dec 31, 2025 | -56.00 Mn |
| Sep 30, 2025 | 557.30 Mn |
| Jun 30, 2025 | 744.00 Mn |
| Mar 31, 2025 | 311.20 Mn |
| Dec 31, 2024 | 291.50 Mn |
| Sep 30, 2024 | 451.00 Mn |
| Jun 30, 2024 | 698.70 Mn |
| Mar 31, 2024 | 464.80 Mn |
| Dec 31, 2023 | 291.60 Mn |
| Sep 30, 2023 | -141.20 Mn |
| Jun 30, 2023 | 708.10 Mn |
| Mar 31, 2023 | 438.30 Mn |
| Dec 31, 2022 | 603.80 Mn |
| Sep 30, 2022 | 1.37 Bn |
| Jun 30, 2022 | 1.27 Bn |
| Mar 31, 2022 | 610.70 Mn |
| Dec 31, 2021 | 587.10 Mn |
API Access
Biogen Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=operating-income&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "operating-income", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=operating-income&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();